Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

December 01, 2009

In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 15, 2012

    Impax Can't Shake Injunction On Generic Amrix

    A Delaware federal judge on Thursday nixed Impax Laboratories Inc.'s bid to amend an injunction barring it from marketing a generic version of Cephalon Inc.'s muscle relaxant Amrix, ruling that a prior settlement does not give Impax the right to sell its generic.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login